Patent ID: 8632807

Claim:
A process for formation of a pharmaceutical formulation comprising a rosuvastatin calcium containing layer, said process comprising a) coating a tablet, pellet or granule core with a sub-coating layer of a hydroxypropyl methylcellulose/polyethylene glycol (HPMC/PEG) coating polymer; and b) spray coating a solution comprising rosuvastatin calcium and an HPMC/PEG polymer in water onto the coated tablet, pellet or granule core to provide the rosuvastatin calcium containing layer; wherein the core contains an active ingredient which is not selected from any one or more of: niacin or a niacin analogue, a fibrate, metformin, a CETP inhibitor and aspirin; and wherein the rosuvastatin calcium containing layer comprises rosuvastatin calcium and the HPMC/PEG polymer in a ratio of approximately 1:1.